Accepted for Publication: February 4, 2022.
Published Online: February 17, 2022. doi:10.1001/jama.2022.2274
Corresponding Author: Kevin A. Brown, PhD, Public Health Ontario, 480 University Ave, Suite 300, Toronto, ON M5G1V2, Canada (kevin.brown@oahpp.ca).
Author Contributions: Ms Ulloa and Dr Brown had full access to all the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis.
Concept and design: All authors.
Acquisition, analysis, or interpretation of data: Ulloa, Brown.
Drafting of the manuscript: All authors.
Critical revision of the manuscript for important intellectual content: All authors.
Statistical analysis: Ulloa, Brown.
Administrative, technical, or material support: Brown.
Supervision: Brown.
Conflict of Interest Disclosures: None reported.
Funding/Support: This study was supported by Public Health Ontario; the authors received no external funding for the conduct of this study.
Role of the Funder/Sponsor: The funder had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.
1.Mannar
D , Saville
JW , Zhu
X ,
et al. SARS-CoV-2 Omicron variant: antibody evasion and cryo-EM structure of spike protein-ACE2 complex.
Science. Published January 20, 2022. doi:
10.1126/science.abn7760PubMedGoogle Scholar 2.Maslo
C , Friedland
R , Toubkin
M , Laubscher
A , Akaloo
T , Kama
B . Characteristics and outcomes of hospitalized patients in South Africa during the COVID-19 Omicron wave compared with previous waves.
JAMA. 2022;327(6):583-584. doi:
10.1001/jama.2021.24868PubMedGoogle ScholarCrossref 6.Ferguson
N , Ghani
A , Hinsley
W , Volz
E ; Imperial College COVID-19 Response Team.
Report 50: Hospitalisation Risk for Omicron Cases in England. Imperial College London; 2021. doi:
10.25561/93035